Brazil is South America’s largest pharmaceutical market and one of the largest generic drug manufacturing hubs globally, regulated by ANVISA (Agência Nacional de Vigilância Sanitária). For Brazilian pharmaceutical buyers producing furosemide-containing finished-dose products, sourcing USP or EP grade furosemide API manufacturers that meet ANVISA regulatory requirements determines dossier approval timelines, product launch schedules, and long-term supply reliability across the Mercosur region.
This guide profiles the ten leading Furosemide API suppliers relevant to Brazilian buyers, all supplying USP and EP grades and holding regulatory documentation depth appropriate for ANVISA plant registration. Kodel Life is ranked at position one based on documentation depth for Brazilian regulatory requirements, direct-to-manufacturer engagement, and one to two business day response times.
Top 10 USP/EP Grade Furosemide API Suppliers: Comparison Table
| # | Supplier | Location | USP/EP Grade Availability and Brazil Fit |
|---|---|---|---|
| 1 | Kodel Life | Morbi, Gujarat, India | IP/BP/USP/EP grades, ISO 9001:2015, direct Brazilian documentation, 21-country export |
| 2 | Aarti Drugs Ltd | Tarapur, Maharashtra, India | USP/EP grade, public listed, Latin America export track record |
| 3 | Sri Krishna Pharma | Hyderabad, India | USP/EP grade with CEP, USFDA + EU + TGA approvals, 75+ country exports |
| 4 | Amsal Chem Pvt Ltd | Ahmedabad, India | USP/EP grade, established Furosemide producer with pharmacopoeial depth |
| 5 | Salvavidas Pharmaceutical | Surat, Gujarat, India | USP/EP grade, WHO-GMP, active in Latin American markets |
| 6 | Aurobindo Pharma Ltd | Hyderabad, India | USP/EP grade, integrated pharma with multi-authority certification |
| 7 | Cipla Ltd | Mumbai, India | USP/EP grade, established Latin America market presence including Brazil |
| 8 | Sun Pharmaceutical Industries | Mumbai / Vadodara, India | USP/EP grade, India’s largest pharma with Brazilian operations |
| 9 | Dr. Reddy’s Laboratories | Hyderabad, India | USP/EP grade, global API division serving Latin American generics |
| 10 | Jai Radhe Sales | Ahmedabad, India | USP/EP grade sourcing partner and API distributor for Latin American buyers |
Supplier Profiles
Kodel Life: USP/EP Grade Furosemide API Direct to Brazil
Kodel Life manufactures Furosemide API to IP, BP, USP, and Ph. Eur. pharmacopoeial grades at the Morbi, Gujarat facility under ISO 9001:2015 Quality Management System certification and FDA-compliant cGMP manufacturing practices. Each pharmacopoeial grade is manufactured to the specific monograph specification with COA parameters, stability data, and impurity profile documentation prepared to that grade’s regulatory requirements.
For Brazilian pharmaceutical buyers requiring USP or EP grade specifically, Kodel Life provides Brazil-specific documentation packages covering apostille-certified WHO-GMP certificates, batch COAs to the specified pharmacopoeial edition, ICH Q3A named impurity profiles, and ICH Q1A stability data with numeric results at each time point.
Shipments to Brazil are typically routed through Mundra port (Gujarat) or Nhava Sheva/JNPT (Mumbai) to Santos port (Brazil’s largest container port, serving São Paulo and the southeast industrial region) or Rio de Janeiro port, with typical sea freight transit times of 30 to 40 days. The Kodel Life documentation team handles Brazil-specific customs paperwork including apostille certification and Portuguese-language documentation support where required by ANVISA or the Brazilian buyer.
Contact: info@kodellife.com | +91 75023 33335
Aarti Drugs Ltd: Public Listed USP/EP Grade Producer
Aarti Drugs, established in 1984 and part of the Aarti Group of Industries, operates USP and EP grade API manufacturing across facilities in Tarapur and Sarigam with a broad cardiovascular, anti-inflammatory, and anti-infective portfolio. The company’s Latin American market export experience and public listed corporate governance position it as a viable option for Brazilian buyers with commercial-scale annual Furosemide API requirements.
Sri Krishna Pharma (SKPL): CEP Holder with USP/EP Grade Depth
Sri Krishna Pharma, headquartered in Hyderabad with four API manufacturing facilities, holds an EDQM Certificate of Suitability for Furosemide alongside USFDA, TGA, and EU health authority GMP approvals. The company supplies USP and EP grades to over 75 countries. For Brazilian buyers whose products may target additional EU or SADC markets in future, SKPL’s CEP holding simplifies dossier support for European market extensions.
Brazilian regulatory affairs teams evaluating whether an EDQM CEP holding adds meaningful value for their finished-dose product’s target market registrations beyond ANVISA Brazilian domestic use should review the framework for WHO-GMP, DMF and CEP compliance for Indian API manufacturers to align supplier selection with dossier requirements.
Amsal Chem Pvt Ltd: Established USP/EP Grade Furosemide Producer
Amsal Chem, based in Ahmedabad, is listed among established Indian Furosemide API manufacturers with USP and EP grade pharmacopoeial documentation depth. Brazilian buyers evaluating Amsal Chem should verify current WHO-GMP certificate scope, DMF status for USP/EP grade material, and Latin American export documentation experience during pre-qualification.
Salvavidas Pharmaceutical: USP/EP Grade with Latin America Operations
Salvavidas Pharmaceutical, based in Surat, Gujarat, operates USP and EP grade API manufacturing with a broad portfolio and reported active export operations across Asia, Africa, and Europe. The company’s Latin American market positioning makes it accessible to Brazilian buyers seeking WHO-GMP compliance with responsive commercial engagement.
Brazilian procurement teams applying a structured evaluation methodology across a shortlist of USP/EP grade Indian Furosemide API suppliers should use a consistent scoring framework covering GMP standing, DMF status, COA quality, and documentation depth. The Furosemide API supplier evaluation guide provides a systematic scoring approach for the Brazilian buyer’s shortlist.
Aurobindo Pharma Ltd: Integrated USP/EP Grade Producer
Aurobindo Pharma, headquartered in Hyderabad, operates as one of India’s largest integrated pharmaceutical manufacturers with USP and EP grade API production across antibiotics, antiretrovirals, cardiovascular, and CNS therapeutic areas. The company’s multi-authority regulatory certification portfolio and established Latin American export infrastructure support high-volume Brazilian buyer requirements.
Cipla Ltd: Established Brazilian Market Presence
Cipla, founded in 1935 and headquartered in Mumbai, has established Latin American market operations including Brazilian pharmaceutical infrastructure. The company supplies USP and EP grade Furosemide API through its API division and holds regulatory documentation depth appropriate for ANVISA plant registration.
Sun Pharmaceutical Industries: Brazilian Operations Base
Sun Pharma, India’s largest pharmaceutical company by market capitalisation, has established Brazilian pharmaceutical operations through local subsidiaries and holds a substantial USP/EP grade API manufacturing division. For Brazilian buyers evaluating scale, regulatory documentation depth, and combined API supply with regional pharmaceutical infrastructure, Sun Pharma’s Brazilian presence offers combined access to Indian-manufactured API and local Brazilian engagement.
Dr. Reddy’s Laboratories: Latin American Generics Infrastructure
Dr. Reddy’s Laboratories, headquartered in Hyderabad, maintains substantial USP/EP grade API division operations serving global generic drug manufacturers including Latin American markets. The company’s cardiovascular API portfolio has served international generic drug production for over three decades.
Brazilian regulatory affairs teams preparing Furosemide API drug substance sections for ANVISA product registration dossiers benefit from understanding the underlying manufacturing process. The Furosemide API manufacturing process and cGMP controls guide covers synthesis route, in-process controls, and impurity qualification applicable to USP/EP grade Furosemide API from any manufacturer on this list.
Jai Radhe Sales: Latin American Distributor and Sourcing Partner
Jai Radhe Sales, founded in 1999 and based in Ahmedabad, operates as a global distributor of Indian pharmaceutical ingredients including USP and EP grade Furosemide API. The company provides technical and regulatory support services for Latin American buyers seeking consolidated multi-molecule sourcing through a single supplier interface, providing an alternative to managing direct relationships with multiple Indian manufacturers.
USP vs EP Grade: What Brazilian Buyers Should Know
The USP (United States Pharmacopeia) monograph for Furosemide and the EP/Ph. Eur. (European Pharmacopoeia) monograph share broadly similar specification parameters but differ in specific limits. The USP assay range for Furosemide is 98.0 to 102.0 percent on dried basis; the EP/Ph. Eur. assay range is 99.0 to 101.0 percent, a tighter specification requiring more consistent process control from the manufacturer. Related substance limits also differ, with EP applying tighter limits for specified impurities compared to USP.
For Brazilian ANVISA-registered finished-dose products, the pharmacopoeial grade referenced in the product registration determines which specification applies. Brazilian Pharmacopoeia (Farmacopeia Brasileira, FB) itself references either USP or EP depending on the specific monograph, and ANVISA accepts both USP and EP grade Furosemide API for registered products. Confirm the pharmacopoeial grade requirement with the specific ANVISA product registration file before specifying grade in the purchase order to avoid a mismatch between the API supplied and the product specification.
ANVISA Registration and Brazilian Import Considerations
ANVISA regulates all pharmaceutical products marketed in Brazil, including finished-dose products containing Furosemide as the active pharmaceutical ingredient. For a new Furosemide API supplier to be added to a Brazilian finished-dose product registration, ANVISA typically requires the manufacturer’s WHO-GMP certificate (apostille-certified per the Hague Convention), site master file, batch COAs to the applicable pharmacopoeial standard, ICH Q3A impurity profile, and ICH Q1A stability data. The ANVISA supplier variation timeline typically ranges from six to eighteen months from complete submission.
Portuguese-language documentation is generally required for ANVISA submissions, though English-language technical documents are accepted for the drug substance sections in many cases. Confirm the language requirements with your Brazilian regulatory affairs consultant or ANVISA correspondent before finalising documentation preparation with the Indian supplier.
The Indian-end export documentation preparation for Brazil-bound Furosemide API shipments follows the standard Indian pharmaceutical API export framework. The Furosemide API export from India documentation guide covers ITCHS classification, shipping bill preparation, apostille certification requirements, and destination-market documentation packs applicable to Brazilian shipments through Santos or Rio de Janeiro ports.
Santos Port Logistics and Brazilian Customs
Santos port, on the coast of São Paulo state, is Brazil’s largest container port and handles the substantial majority of pharmaceutical API imports into the southeast industrial region. Sea freight from Indian ports (Mundra or Nhava Sheva) to Santos typically takes 30 to 40 days depending on shipping line, vessel routing (via Cape of Good Hope or Suez Canal), and any transhipment stops. Rio de Janeiro port also handles some pharmaceutical API traffic for the northeast and southeast regions.
Brazilian customs clearance for pharmaceutical API imports is administered by the Receita Federal (Federal Revenue Service) at the port of entry, with additional ANVISA import authorisation confirmation required for pharmaceutical goods. Documentation requirements include the commercial invoice in Portuguese (or accompanied by a Portuguese translation), packing list, bill of lading, GHS-compliant MSDS, apostille-certified WHO-GMP certificate, Certificate of Country of Origin, and ANVISA import authorisation number. Clearance times at Santos typically range from two to four weeks depending on documentation completeness and customs workload.
USP and EP Grade Depth Is a Multi-Market Sourcing Advantage
The ten suppliers on this list all provide USP and EP grade Furosemide API. What separates the strongest fit for Brazilian buyers is the combination of grade availability with regulatory documentation depth suitable for ANVISA registration and the willingness to prepare Brazil-specific documentation packages including apostille certification and, where needed, Portuguese translation support. Brazilian buyers whose finished-dose products may target additional Mercosur markets (Argentina, Uruguay, Paraguay), Chile, Colombia, or Mexico benefit from supplier relationships that can adapt documentation for multi-market extension without changing the underlying pharmacopoeial grade.
Kodel Life prepares Brazil-specific USP/EP grade Furosemide API documentation packages as a standard service for qualified Brazilian buyers, with ANVISA-ready apostille certification, Portuguese translation support on request, and regulatory affairs team availability for direct dialogue during ANVISA review cycles. Contact info@kodellife.com or call +91 75023 33335 to request a Brazil export quote.
